Categorías

Últimos comentarios

Search


Archivo

Últimos artículos


« Inflation Overtakes Wages In January | Inicio | U.S. Consumers Not Keeping Up »

Wyeth Breaks From Solvay

By Anita Broker | February 29, 2008

The American drug company says that it isn’t worth collaborating on a psychiatric drug.

forbes.com/markets/2008/02/29/wyeth-solvay-drugs-markets-equity-c

Categoría: Forbes: Markets News |

Comments